Author

C. Jacklin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

E. Johnson· 1 shared M. D. Moore· 1 shared O. Green· 1 shared S. Johnson· 1 shared W. S. James· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

E. Johnson

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SAMHD1 controls nucleoside-based cancer therapeutics, deoxyguanosine toxicity, and inflammation

M. D. Moore, E. Johnson, C. Jacklin, S. Johnson, O. Green, W. S. James

This study shows that SAMHD1 knockout affects nucleoside analogue sensitivity, deoxyguanosine toxicity, and inflammation in macrophages, linking it to Acardi-Goutieres Syndrome and cancer therapies.

bioRxiv · Aug 25, 2022 · PreprintPharmacology & Toxicology